152 related articles for article (PubMed ID: 2530142)
1. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].
Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S
Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142
[TBL] [Abstract][Full Text] [Related]
2. [Behavioral effects of quinupramine, a new tricyclic antidepressant].
Ueki S; Yamamoto T; Shimazoe T; Shibata S; Tani Y; Machida K; Hojo M; Yoshida Y; Tatsumi H
Nihon Yakurigaku Zasshi; 1988 Jun; 91(6):359-69. PubMed ID: 3417209
[TBL] [Abstract][Full Text] [Related]
3. [Behavior pharmacology of maprotiline, a new antidepressant].
Ueki S; Fujiwara M; Inoue K; Kataoka Y; Ibii N
Nihon Yakurigaku Zasshi; 1975 Nov; 71(8):789-815. PubMed ID: 1240830
[TBL] [Abstract][Full Text] [Related]
4. [Behavioral pharmacology of a new antidepressant, lopramine].
Ueki S; Fujiwara M; Inoue K
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):585-607. PubMed ID: 1033109
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological properties of MO-8282, a novel antidepressant].
Niho T; Ito C; Shibutani Y; Hashizume H; Yamaguchi K
Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):309-20. PubMed ID: 3792961
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
Subarnas A; Tadano T; Oshima Y; Kisara K; Ohizumi Y
J Pharm Pharmacol; 1993 Jun; 45(6):545-50. PubMed ID: 8103103
[TBL] [Abstract][Full Text] [Related]
7. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)].
Kamioka T; Sakai Y
Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623
[TBL] [Abstract][Full Text] [Related]
8. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Worms P; Kan JP; Wermuth CG; Roncucci R; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies.
Meignen J; Grognet A; Deniard MJ; Dalphrase F; Roux E; DeFeudis FV
Gen Pharmacol; 1982; 13(5):381-91. PubMed ID: 6890919
[TBL] [Abstract][Full Text] [Related]
10. [Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].
Fujiwara M; Sakurai Y; Kiyota Y; Shimazoe T; Ohta H; Shibata S; Ueki S
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):259-74. PubMed ID: 2989132
[TBL] [Abstract][Full Text] [Related]
11. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
Yokota S; Ishikura Y; Ono H
Jpn J Pharmacol; 1987 Nov; 45(3):335-42. PubMed ID: 2963926
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
[TBL] [Abstract][Full Text] [Related]
15. [Behavioral pharmacological and electroencephalographic effects of the 5-HT1A partial agonist ipsapirone].
Yamamoto T; Shibata S; Teshima K; Inoue Y; Ushio M; Tominaga K; Ohno M; Watanabe S; Ueki S
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):41-52. PubMed ID: 1679740
[TBL] [Abstract][Full Text] [Related]
16. Electroencephalographic effects of the new antidepressant paroxetine in the rabbit.
Watanabe S; Ohta H; Ohno M; Tani Y; Furuya Y; Ueki S; Man'no K; Sugihara K
Arzneimittelforschung; 1988 Mar; 38(3):332-40. PubMed ID: 2968081
[TBL] [Abstract][Full Text] [Related]
17. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
Lippman W; Pugsley TA
Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
[TBL] [Abstract][Full Text] [Related]
18. [Specific inhibitory action of a novel antidepressant paroxetine on 5-HT uptake].
Tanigaki N; Manno K; Sugihara K; Miki N; Ichida S; Yoshida H
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):175-80. PubMed ID: 3038714
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
Chaput Y; de Montigny C; Blier P
Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Ozerov AA; Bagmetova VV; Chernysheva YV; Tyurenkov IN
Bull Exp Biol Med; 2016 Mar; 160(5):649-52. PubMed ID: 27021092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
